XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2Close
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Apr. 28, 2024
Apr. 30, 2023
Jan. 28, 2024
Cash flows from operating activities:      
Net income $ 14,881 $ 2,043  
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation expense 1,011 735  
Depreciation and amortization 410 384  
Realized and unrealized (gains) losses on investments in non-affiliated entities, net (69) 14  
Deferred income taxes (1,577) (1,135)  
Other (145) (34)  
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable (2,366) (252)  
Inventories (577) 566  
Prepaid expenses and other assets (726) (215)  
Accounts payable (22) 11  
Accrued and other current liabilities 4,202 689  
Other long-term liabilities 323 105  
Net cash provided by operating activities 15,345 2,911   Close
Cash flows from investing activities:      
Proceeds from maturities of marketable securities 4,004 2,512  
Proceeds from sales of marketable securities 149 0  
Purchases of marketable securities (9,303) (2,801)  
Purchases related to property and equipment and intangible assets (369) (248)  
Acquisitions, net of cash acquired (39) (83)  
Investments in non-affiliated entities (135) (221)  
Net cash used in investing activities (5,693) (841)   Close
Cash flows from financing activities:      
Proceeds related to employee stock plans 285 246  
Payments related to repurchases of common stock (7,740) 0  
Payments related to tax on restricted stock units (1,752) (507)  
Dividends paid (98) (99)  
Principal payments on property and equipment and intangible assets (40) (20)  
Net cash used in financing activities (9,345) (380)   Close
Change in cash and cash equivalents 307 1,690   Close
Cash and cash equivalents at beginning of period 7,280 3,389 $ 3,389
Cash and cash equivalents at end of period $ 7,587 $ 5,079 $ 7,280